Kaijie Biopharm Co. Ltd. (KJ) is one of the leading peptide manufacturers in China. It was founded in 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years.
KJ has oriented its business along two main lines: the investigation, development, production and commercialization of generic bulk peptide APIs for the international markets, and custom synthesis service for building blocks, amino acid resin and peptide sequences which meet research specific demand worldwide.
The pharmaceutical grade solid phase peptide synthesis can meet USP, EP or the requirements of CP, single batches are up to Kg scales.
KJ has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale. Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.
Our Mission:
To combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.
KJ has oriented its business along two main lines: the investigation, development, production and commercialization of generic bulk peptide APIs for the international markets, and custom synthesis service for building blocks, amino acid resin and peptide sequences which meet research specific demand worldwide.
The pharmaceutical grade solid phase peptide synthesis can meet USP, EP or the requirements of CP, single batches are up to Kg scales.
KJ has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale. Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.
Our Mission:
To combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.
